Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
10102-cover1-opener.jpg

January 16, 2023 Cover

Volume 101, Issue 2

We analyze the business trends, government policies, and societal forces that will affect chemistry in the year ahead

Cover image:We analyze the business trends, government policies, and societal forces that will affect chemistry in the year ahead.

Credit: Shutterstock

Full Article
Volume 101 | Issue 2

All Issues

Quote of the Week

“The whole foundation of working to achieve environmental justice is local.”

Peggy Shepard, executive director, We Act for Environmental Justice

C&EN’s World Chemical Outlook 2023

We analyze the business trends, government policies, and societal forces that will affect chemistry in the year ahead

  • US Chemical Safety Board issues delayed accident reports

    CSB also identifies hundreds of serious incidents in the last 2.5 years

  • FDA green-lights lecanemab to treat Alzheimer’s disease

    The developers list an annual price of $26,500 per patient

  • Fireproof polymer electrolyte for high-performance batteries

    Adding extra salt to a rubbery polymer creates a safer electrolyte for lithium-ion batteries

ADVERTISEMENT
image name
Pharmaceuticals

J.P. Morgan Healthcare Conference returns to San Francisco

Rare disease M&A’s, on-site enthusiasm mark 2023 meeting

ADVERTISEMENT
ADVERTISEMENT